Filing Flows › Orthofix Medical (OFIX) › Q1 FY26
Orthofix Medical (OFIX) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed May 5, 2026
Orthofix Medical (OFIX) reported revenue of $197M for the first quarter fiscal 2026 (Q1 FY26), +2% from a year earlier and -11% from the quarter before. Operating margin was -7.3%, net loss $20.9M (10.6% of revenue).
Orthofix Medical, Q1 FY26: revenue $197M (+2% year over year), operating margin -7.3%, net loss $20.9M, operating cash flow −$17.6M. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $197M | -11% | +2% |
| Operating profit | −$14.4M | -3022% | — |
| Net earnings | −$20.9M | — | — |
| Operating cash flow | −$17.6M | -164% | — |
What changed
Revenue was $196.7M in Q1 FY26, up 2% year over year and down 11% from the previous quarter. Global Spine was the largest line at 83% of revenue. Global Limb Reconstruction added $3.0M year over year (up 10%), 99% of the total change.
Gross margin was 70.9%, up 8.1 points from Q1 FY25. Operating costs exceeded revenue by $14.4M, an operating margin of -7.3%. Operating expenses fell 10% while revenue rose 2%. The quarter ended with a net loss of $20.9M, wider than the previous quarter's $2.2M loss.
Operating cash flow was −$17.6M. Non-cash charges added back $13.5M of depreciation and amortization and $6.5M of share-based compensation. Working capital and other items used $16.7M. Capital expenditures of $10.7M exceeded it, leaving free cash flow of −$28.3M.
Questions
What was Orthofix Medical's revenue in the first quarter fiscal 2026?
Orthofix Medical (OFIX) reported revenue of $197M for the first quarter fiscal 2026 (Q1 FY26), +2% from a year earlier and -11% from the quarter before.
Was Orthofix Medical profitable in the first quarter fiscal 2026?
Operating loss was $14.4M (-7.3% of revenue) and net loss $20.9M.
Source: Orthofix Medical 10-Q on SEC EDGAR.